Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0085110 (
SCID
)
11,041
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
PKL12/STK16 protein is the first identified mammalian member of a ser/thr kinase subfamily that is conserved across several kingdoms, with a broad expression pattern in murine tissues and cell types. Endogenous
STK16
subcellular localization was evaluated by indirect immunofluorescence in NIH/3T3 and NRK cells, demonstrating a Golgi-associated pattern that appears to be independent of signals provided by integrin pathways. When cells were treated with brefeldin A (BFA) or nocodazole, drugs that promote Golgi disorganization, we observed
STK16
translocation to the nuclear compartment. Constitutive overexpression of this protein by retroviral vectors also promotes accumulation of
STK16
in the nuclear compartment, as shown by subfractionation studies. A kinase-dead
STK16
mutant (E202A) was used to demonstrate that both the Golgi association and the nuclear translocation capabilities seem to be independent of the
STK16
kinase activity. In addition, we show that
STK16
overexpression in several cell lines enhances their capacity to produce and secrete VEGF. To confirm these data in vivo, we injected tumor cells overexpressing
STK16
into immunodeficient BALBc/
SCID
mice. HT1080-derived tumors overexpressing
STK16
showed increased volume and number of blood vessels compared to controls. Altogether, these data concur with previous reports suggesting a potential role for
STK16
as a transcriptional co-activator.
...
PMID:Nucleocytoplasmic shuttling of STK16 (PKL12), a Golgi-resident serine/threonine kinase involved in VEGF expression regulation. 1631 Jul 70